Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using heart rate variability to guide brain stimulation for depression

Official title: HRV-Guided tDCS: Integrating A Biomarker For Clinical Utility

Run by NYU Langone Health · NCT06455527 · Data updated 2026-11-12

This study is testing if using heart rate data to guide brain stimulation can help people with mild to moderate depression feel better.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorNYU Langone Health
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedJanuary 2, 2025
Main results expectedNovember 1, 2027
Study endsNovember 1, 2027
Registry record updatedSeptember 25, 2026
Trial IDNCT06455527 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults with mild to moderate depression as indicated by specific diagnostic criteria.

Probably not a fit

Patients with severe psychiatric disorders, significant medical conditions, or high suicidality risk may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to evaluate the effectiveness of heart rate variability (HRV)-guided transcranial direct current stimulation (tDCS) in individuals with mild to moderate depression. A total of 100 participants will be recruited to undergo a double-blinded, parallel-arm, sham-controlled intervention at home, where they will receive either active or sham tDCS for 30 minutes over 10 days. The study will collect heart rate data during sessions to identify potential markers of response to the treatment. Participants will be randomized in a 2:1 ratio to receive either the active or sham stimulation.

Why it matters

Potential benefit: If successful, this approach could provide a novel, non-invasive treatment option for individuals suffering from depression.

How similar studies have gone: While the use of tDCS has been explored in other studies, the specific HRV-guided approach is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Mild to moderate depression (Beck Depression Inventory(BDI)-II 14-28)
* Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-V-TR) Depressive episode
* Wide Range Achievement Test (WRAT)-4th Reading Recognition subtest standard score \>85

Exclusion Criteria:

* Primary neurologic, psychiatric (e.g., multiple sclerosis, stroke, Parkinson's disease, spinal cord injury, intracranial mass, traumatic brain injury (TBI), epilepsy, mild cognitive impairment (MCI), or dementia), or major medical disorder (e.g., history of myocardial infarction, diabetes, thyroid disease, arrhythmia, atrial fibrillation) (medical history review)
* DSM-V-TR bipolar depression, psychotic disorder, or alcohol or substance use disorder (M.I.N.I.)
* Active or high suicidality risk (Columbia-Suicide Severity Rating Scale, C-SSRS), or otherwise judged as inappropriate by the study clinicians
* History of a heart transplant, presence of permanent pacemaker implant or Left Ventricular Assist Device
* Use of certain medications that can affect heart rate variability, such as beta-blockers, calcium channel blockers, or cardiac glycosides
* Use of antidepressant, antipsychotic, anxiolytic, or stimulant medications
* Pregnant or planning pregnancy during the study period
* Seizure disorder or recent (\<5 years) seizure history
* Presence of metal objects in the head/neck
* Any skin disorder or skin sensitive area near stimulation locations

Where it's running

  • NYU Langone Health
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.